Culturally-adapted Mobile Health Intervention for Hypertension Care
Launched by TUFTS UNIVERSITY · May 14, 2025
Trial Information
Current as of July 23, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • diagnosis of hypertension
- Exclusion Criteria:
- • Comorbidities
About Tufts University
Tufts University is a prestigious research institution renowned for its commitment to advancing health and medicine through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Tufts leverages its expertise in biomedical research, public health, and clinical practice to design and conduct rigorous studies that address critical health challenges. The university's clinical trial programs are characterized by their adherence to high ethical standards and regulatory compliance, ensuring the safety and well-being of participants while contributing valuable insights to the scientific community. Through its dedication to fostering education and research, Tufts University plays a vital role in translating findings into effective health interventions and policies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Accra, , Ghana
Ho, , Ghana
Patients applied
Trial Officials
Valencia Koomson
Principal Investigator
Tufts University
Mark Tettey, MD
Principal Investigator
University of Ghana
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported